Report Detail
Global Immuno Oncology Assays Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3741093 |
- 11 September, 2019 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Other
Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
Scope of the Report:
The global Immuno Oncology Assays market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immuno Oncology Assays.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Immuno Oncology Assays market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immuno Oncology Assays market by product type and applications/end industries.
Market Segment by Companies, this report covers
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing
Market Segment by Applications, can be divided into
Research
Clinical Diagnostics
Table of Contents
1 Immuno Oncology Assays Market Overview
- 1.1 Product Overview and Scope of Immuno Oncology Assays
- 1.2 Classification of Immuno Oncology Assays by Types
- 1.2.1 Global Immuno Oncology Assays Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Immuno Oncology Assays Revenue Market Share by Types in 2018
- 1.2.3 Immunoassay
- 1.2.4 Flow Cytometry
- 1.2.5 PCR
- 1.2.6 Next Generation Sequencing
- 1.3 Global Immuno Oncology Assays Market by Application
- 1.3.1 Global Immuno Oncology Assays Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Research
- 1.3.3 Clinical Diagnostics
- 1.4 Global Immuno Oncology Assays Market by Regions
- 1.4.1 Global Immuno Oncology Assays Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Immuno Oncology Assays Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Immuno Oncology Assays Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immuno Oncology Assays Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Immuno Oncology Assays Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immuno Oncology Assays Status and Prospect (2014-2024)
- 1.5 Global Market Size of Immuno Oncology Assays (2014-2024)
2 Manufacturers Profiles
- 2.1 Thermo Fischer Scientific
- 2.1.1 Business Overview
- 2.1.2 Immuno Oncology Assays Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Thermo Fischer Scientific Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Roche Diagnostics
- 2.2.1 Business Overview
- 2.2.2 Immuno Oncology Assays Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Roche Diagnostics Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Agilent Technologies
- 2.3.1 Business Overview
- 2.3.2 Immuno Oncology Assays Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Agilent Technologies Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Illumina
- 2.4.1 Business Overview
- 2.4.2 Immuno Oncology Assays Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Illumina Immuno Oncology Assays Revenue, Gross Margin and Market Share (2017-2018)
3 Global Immuno Oncology Assays Market Competition, by Players
- 3.1 Global Immuno Oncology Assays Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Immuno Oncology Assays Players Market Share
- 3.2.2 Top 10 Immuno Oncology Assays Players Market Share
- 3.3 Market Competition Trend
4 Global Immuno Oncology Assays Market Size by Regions
- 4.1 Global Immuno Oncology Assays Revenue and Market Share by Regions
- 4.2 North America Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 4.3 Europe Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 4.5 South America Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
5 North America Immuno Oncology Assays Revenue by Countries
- 5.1 North America Immuno Oncology Assays Revenue by Countries (2014-2019)
- 5.2 USA Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 5.3 Canada Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
6 Europe Immuno Oncology Assays Revenue by Countries
- 6.1 Europe Immuno Oncology Assays Revenue by Countries (2014-2019)
- 6.2 Germany Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 6.3 UK Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 6.4 France Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 6.5 Russia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 6.6 Italy Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Immuno Oncology Assays Revenue by Countries
- 7.1 Asia-Pacific Immuno Oncology Assays Revenue by Countries (2014-2019)
- 7.2 China Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 7.3 Japan Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 7.4 Korea Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 7.5 India Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
8 South America Immuno Oncology Assays Revenue by Countries
- 8.1 South America Immuno Oncology Assays Revenue by Countries (2014-2019)
- 8.2 Brazil Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Immuno Oncology Assays by Countries
- 9.1 Middle East and Africa Immuno Oncology Assays Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 9.3 UAE Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Immuno Oncology Assays Revenue and Growth Rate (2014-2019)
10 Global Immuno Oncology Assays Market Segment by Type
- 10.1 Global Immuno Oncology Assays Revenue and Market Share by Type (2014-2019)
- 10.2 Global Immuno Oncology Assays Market Forecast by Type (2019-2024)
- 10.3 Immunoassay Revenue Growth Rate (2014-2024)
- 10.4 Flow Cytometry Revenue Growth Rate (2014-2024)
- 10.5 PCR Revenue Growth Rate (2014-2024)
- 10.6 Next Generation Sequencing Revenue Growth Rate (2014-2024)
11 Global Immuno Oncology Assays Market Segment by Application
- 11.1 Global Immuno Oncology Assays Revenue Market Share by Application (2014-2019)
- 11.2 Immuno Oncology Assays Market Forecast by Application (2019-2024)
- 11.3 Research Revenue Growth (2014-2019)
- 11.4 Clinical Diagnostics Revenue Growth (2014-2019)
12 Global Immuno Oncology Assays Market Size Forecast (2019-2024)
- 12.1 Global Immuno Oncology Assays Market Size Forecast (2019-2024)
- 12.2 Global Immuno Oncology Assays Market Forecast by Regions (2019-2024)
- 12.3 North America Immuno Oncology Assays Revenue Market Forecast (2019-2024)
- 12.4 Europe Immuno Oncology Assays Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Immuno Oncology Assays Revenue Market Forecast (2019-2024)
- 12.6 South America Immuno Oncology Assays Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Immuno Oncology Assays Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Immuno Oncology Assays. Industry analysis & Market Report on Immuno Oncology Assays is a syndicated market report, published as Global Immuno Oncology Assays Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Immuno Oncology Assays market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
